This paper is in the following e-collection/theme issue:

Consumer & Patient Education and Shared-Decision Making (679) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Pharmacovigilance (134)

Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40616, first published .
Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study

Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study

Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study

Authors of this article:

Peter Johannes Schulz1, 2, 3 Author Orcid Image ;   Francesca Crosignani1 Author Orcid Image ;   Serena Petrocchi4 Author Orcid Image
Article Authors Cited by (1) Tweetations (3) Metrics

Peter Johannes Schulz   1, 2, 3 , MA, PhD ;   Francesca Crosignani   1 , MSc ;   Serena Petrocchi   4 , MSc, PhD

1 Faculty of Communication, Culture and Society, Università della Svizzera italiana, Lugano, Switzerland

2 Department of Communication & Media, Ewha Womans University, Seoul, Republic of Korea

3 Wee Kim Wee School of Communication and Information & Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

4 Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland

Corresponding Author:

  • Peter Johannes Schulz, MA, PhD
  • Faculty of Communication, Culture and Society
  • Università della Svizzera italiana
  • 13 via buffi
  • Lugano, 6900
  • Switzerland
  • Phone: 41 586664757
  • Email: peter.schulz@usi.ch